Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 8—August 2021

Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011–2016

Amrei KringsComments to Author , Josephine Jacob, Frank Seeber, Uwe Pleyer, Jochen Walker, Klaus Stark, and Hendrik Wilking
Author affiliations: Robert Koch Institute, Berlin, Germany (A. Krings, F. Seeber, K. Stark, H. Wilking); European Centre for Disease Prevention and Control, Stockholm, Sweden (A. Krings); InGef–Institute for Applied Health Research Berlin GmbH, Berlin (J. Jacob, J. Walker); Charité Universitätsmedizin Berlin, Berlin (U. Pleyer)

Main Article

Table 7

Underlying conditions among patients with ocular, cerebral, or other toxoplasmosis manifestations, Germany, 2012–2016

Condition Odds ratio (95% CI)
Epilepsy 2.1 (1.3–3.3)
Visual loss, blindness, etc. 2.7 (1.7–4.3)
Anxiety 1.5 (1.2–1.8)
Thrombocytopenia 3.2 (1.7–6.1)
Lymphadenopathy 6.0 (3.9–9.3)

Main Article

Page created: June 16, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.